SCHEMBL19997394

SCHEMBL19997394

COc1nc(S(C)(=O)=O)nn2c([C@]3(O)O[C@@H]4C(OCc5ccccc5)[C@]4(OCc4ccccc4)[C@@]3(C)OCc3ccccc3)cnc12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19997433 0.91 TLR7 (0.31) —
SCHEMBL23278043 0.91 TLR7 (0.31) —
SCHEMBL12393239 0.82 — —
SCHEMBL19997408 0.82 — —
SCHEMBL24168593 0.80 DCPS (0.31) —
SCHEMBL14038962 0.79 TP53 (0.30) —
SCHEMBL20380391 0.78 TLR7 (0.30) —
SCHEMBL19997384 0.78 — —
SCHEMBL19997395 0.78 — —
SCHEMBL19997428 0.78 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE46762-E1 1′-substituted carba-nucleoside analogs for antiviral treatment GILEAD SCIENCES, INC (US) 2018-03-27 — — US disclosed
Send feedback